Korro Bio

KRRONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$152.263 M

$10.34 +3.61%

Close of 22 Sept 2026

Revenue

$6.39M

#3242 by revenue

Earnings

-$117.3M

Loss-making

Shares outstanding

14,725,646

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#283Organigram GlobalOGI$156.5M
#284Corbus PharmaceuticalsCRBP$152.3M
#285Korro BioKRRO$152.3M
#286ImmunicIMUX$147.9M
#287NRX PharmaceuticalsNRXP$143.7M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Korro Bio, worth $78.8K. Grants and option exercises are excluded.

Lynx1 Capital Management LP, Weston Nichols$78.8K
6,684 shares at $11.79 on 6 Aug 2026 · filed 13 Aug 2026

What if Korro Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,053,151

Per share 198,564× higher

Bitcoin $1.74T

$118,273.59

Per share 11,438× higher

Nvidia $5.52T

$374,568.76

Per share 36,225× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Korro Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.